Seres Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Seres Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Seres Therapeutics Inc
Rating: 3.02483325
Author: Trendlyne DVM scores

about

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company ar...

12.57 0.22 (1.78%)

New 52W High today

56,646

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Mid Valuation

39.8 / 100

Technically Bullish

81.2 / 100

1Yr Price target downside is -70%

5 analysts

Seres Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Seres Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company ar...

New 52W High today

SWOT Analysis

Seres Therapeutics Inc Live Price Chart